Florida Plaintiff’s Yaz Lawsuit Claims Bayer Ignored Risks
Florida resident Vanessa N. Ortiz filed a Yaz and Yasmin lawsuit on October 25, 2011. According to her Yaz lawyer, Ortiz took the birth control pill at various times between 2006 and 2009, and ended up in the hospital August 5, 2010, allegedly because of Yaz gallbladder disease and complications. According to her Yaz and Yasmin lawsuit, she now requires long-term medical care and medications to treat her injuries.
Yaz and Yasmin lawsuit identified as MDL tag-along
Studies have indicated that Yaz, Yasmin, Ocella, and other birth control pills containing the newer, “fourth generation” progestin drospirenone, put women at a higher risk of side effects like Yaz blood clots, gallbladder disease, pulmonary embolism, and more. Ortiz’s Yaz and Yasmin lawsuit has been removed to the U.S. District Court for the Southern District of Florida and identified as a “tag-along” to the current multidistrict litigation (MDL) in the Southern District of Illinois.
Yaz blood clots one of several alleged side effects
The current Yaz and Yasmin lawsuit MDL may soon be coordinating Ortiz’s Yaz and Yasmin lawsuit along with 6,000 other cases filed by a Yaz lawyer alleging side effects like Yaz blood clots. Plaintiffs like Ortiz who have sought the advice of a Yaz lawyer claim that manufacturer Bayer should have conducted further studies to better establish the safety of the pills before releasing them on the market.
Yaz blood clots may form in the deep veins, a condition known as deep vein thrombosis (DVT). These Yaz blood clots may then travel up to the heart or the lungs, potentially causing life-threatening conditions such as those claimed by plaintiffs who, along with their Yaz lawyer, file a Yaz or Yasmin lawsuit.
Plaintiff and Yaz lawyer claim defendants ignored increased risks
According to Ortiz and her Yaz lawyer, the defendants in this Yaz and Yasmin lawsuit ignored the increased risks of Yaz blood clots and gallbladder disease associated with their birth control pills, and urged girls and women to use their products through marketing and advertising campaigns.
These campaigns, according to Ortiz’s Yaz lawyer, failed to adequately reveal the health dangers, including the risk of Yaz blood clots, while exaggerating the benefits. In her Yaz and Yasmin lawsuit complaint, the plaintiff cites the fact that the FDA issued two warning letters to the company in 2003 and 2008 because of misleading advertisements.
Yaz and Yasmin lawsuit one of many claiming Yaz gallbladder disease
Ortiz joins other plaintiffs who have hired a Yaz lawyer after allegedly developing Yaz gallbladder disease. Like Yaz blood clots, Yaz gallbladder disease can lead to additional problems like infections, abdominal pain, gallstones, fever, and jaundice, and may sometimes require surgery.
The first Yaz and Yasmin lawsuit alleging gallbladder disease in the current MDL is scheduled to go to trial April 2012. Cases filed by a Yaz lawyer alleging Yaz blood clots are scheduled for early 2012.
